Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Erytech Pharma S.A.

News headline image
Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
PHAXIAM Therapeutics announces a reverse share split of its shares
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Responds to Akkadian’s Disinformation
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Provides Update on the Announced Combination with PHERECYDES
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Provides Business and Financial Update for the First Quarter of 2023
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
ERYTECH Announces Receipt of Nasdaq Notice
From Erytech Pharma S.A.
Via GlobeNewswire
News headline image
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
From Erytech Pharma S.A.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.